|
Active substance |
Velmanase alfa |
|
Holder |
Chiesi Farmaceutici S.p.A. |
|
Status |
Running |
|
Indication |
Treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis |
|
Public documents |
|
| Approbation amendment | |
|
Last update |
29/07/2022 |
Velmanase alfa®
Last updated on 23/03/2023